CIK 0001740279
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
IN8BIO, INC.
Sign in to watch- Ticker
- INAB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825462585
- Phone
- +1 646-600-6438
- Business address
- EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
- Former names
- Incysus Therapeutics, Inc.
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 424B4 Offering Prospectus
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 424B4 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1/A Offering Registration Statement
Page 2 of 3 · 48 filings